OrbiMed led a USD80m round for LifeWell, a new brand resulting from the merger of India-based telemedicine platform MFine and India-based stem cell bank LifeCell International’s diagnostic business. In 2021, MFine raised a USD48m Series C round led by Moore Strategic Ventures and Beenext. Lifecell backers include OrbiMed Asia Partners IV, Helion Venture Partners and Brand Capital. Read more